Why This Seattle Biotech Could be an M&A Target Post author:Sam Post published:January 18, 2018 Post category:BioPharma Immune Design is a clinical-stage immunotherapy company. Source: BioSpace You Might Also Like IDEAYA Biosciences Nabs $94 Million March 14, 2018 Is There A Silver Lining For Fitbit? February 14, 2017 COO and First Employee of Editas Medicine to Exit, Effective March 31 March 5, 2017
